- Report
- August 2026
- 115 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- August 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 317 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 114 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 180 Pages
Global
From €4999EUR$5,500USD£4,298GBP
- Report
- July 2026
- 112 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- July 2026
- 115 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- May 2026
- 180 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- May 2026
- 110 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- April 2026
- 180 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- April 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- April 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- April 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- January 2026
- 111 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- August 2026
- 150 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- August 2026
- 120 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- August 2026
- 113 Pages
Global
From €4318EUR$4,750USD£3,712GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more